THE DEAL, AT A GLANCE
From the announcementImmuneel
01What it doesKiran Mazumdar-Shaw's Immuneel is a Bengaluru-based Digital Health company focused on scale CAR-T therapies - The HinduBusinessLine.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by new investors, including Singularity AMC, Zerodha-backed Rainmatter</strong>, as it looksFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedImmuneel raised $12M Series B, announced 2026-06-08From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersImmuneel's $12M Series B is a small Healthcare & Life Sciences financing relative to the sector's recent capital flow, signaling selective support for a Bengaluru-based…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Immuneel · Financing Record
Explore source-linked visual explanations for Immuneel. Unsupported claims are withheld while source review continues.
Record 5708 · Recorded date: 2026-06-08
Explore company records →